Routine follow-up is appropriate for recurrent injection site reactions that, while not severe, significantly impact quality of life or treatment adherence
If your trial has come to an end, you can subscribe here
In India, the market potential is huge with an estimated 10 crore people suffering from diabetes and obesity each
Dean Robinson, a member of the Massachusetts Society of Professors at UMass Amherst, and the MTA's representative on the GIC, told the commission before its vote that it did not make sense to separate the issues of obesity and illnesses related to obesity
This blend has been optimized for the best possible absorption of berberine in order to help you tackle your weight loss goals
Mounjaro (tirzepatide): A GLP-1/GIP dual agonist medication indicated for type 2 diabetes, while its counterpart Zepbound focuses on weight loss